{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:12:38Z","timestamp":1783559558781,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Metabolites detectible in human biofluids are attractive biomarkers for the diagnosis of early Lyme disease (ELD), a vector-borne infectious disease. Urine represents an easily obtained clinical sample that can be applied for diagnostic purposes. However, few studies have explored urine for biomarkers of ELD. In this study, metabolomics approaches were applied to evaluate small molecule metabolites in urine from patients with ELD (n\u2009=\u200914), infectious mononucleosis (n\u2009=\u200914) and healthy controls (n\u2009=\u200914). Metabolic biosignatures for ELD versus healthy controls and ELD versus infectious mononucleosis were generated using untargeted metabolomics. Pathway analyses and metabolite identification revealed the dysregulation of several metabolic processes in ELD as compared to healthy controls or mononucleosis, including metabolism of tryptophan. Linear discriminant analyses demonstrated that individual metabolic biosignatures can correctly discriminate ELD from the other patient groups with accuracies of 71 to 100%. These data provide proof-of-concept for use of urine metabolites as biomarkers for diagnostic classification of ELD.<\/jats:p>","DOI":"10.1038\/s41598-018-29713-y","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T13:43:44Z","timestamp":1533822224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Identification of Urine Metabolites as Biomarkers of Early Lyme Disease"],"prefix":"10.1038","volume":"8","author":[{"given":"Adoracion","family":"Pegalajar-Jurado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryna L.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Nurul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Belisle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary P.","family":"Wormser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathlene S.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura V.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristofor J.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Delorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia R.","family":"Molins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,15]]},"reference":[{"key":"29713_CR1","doi-asserted-by":"crossref","unstructured":"Hinckley, A. F. et al. Lyme disease testing by large commercial laboratories in the United States. Clinical Infectious Diseases, ciu397 (2014).","DOI":"10.1093\/cid\/ciu397"},{"key":"29713_CR2","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.3201\/eid2109.150417","volume":"21","author":"CA Nelson","year":"2015","unstructured":"Nelson, C. A. et al. Incidence of clinician-diagnosed Lyme disease, United States, 2005\u20132010. Emerging infectious diseases 21, 1625 (2015).","journal-title":"Emerging infectious diseases"},{"key":"29713_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek, G., Wormser, G. P., Gray, J. & Strle, F. Lyme borreliosis. The Lancet 379, 461\u2013473 (2012).","journal-title":"The Lancet"},{"key":"29713_CR4","first-page":"590","volume":"44","author":"CFD Control","year":"1995","unstructured":"Control, C. F. D., Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR. Morbidity and mortality weekly report 44, 590 (1995).","journal-title":"MMWR. Morbidity and mortality weekly report"},{"key":"29713_CR5","doi-asserted-by":"publisher","unstructured":"Aguero-Rosenfeld, M. E. Lyme disease: laboratory issues. Infect Dis Clin North Am 22, 301\u2013313, vii, https:\/\/doi.org\/10.1016\/j.idc.2007.12.005 (2008).","DOI":"10.1016\/j.idc.2007.12.005"},{"key":"29713_CR6","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1469-0691.2011.03749.x","volume":"18","author":"V Seriburi","year":"2012","unstructured":"Seriburi, V., Ndukwe, N., Chang, Z., Cox, M. E. & Wormser, G. P. High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice. Clin Microbiol Infect 18, 1236\u20131240, https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03749.x (2012).","journal-title":"Clin Microbiol Infect"},{"key":"29713_CR7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser, G. P. et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43, 1089\u20131134, https:\/\/doi.org\/10.1086\/508667 (2006).","journal-title":"Clin Infect Dis"},{"key":"29713_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.idc.2007.12.012","volume":"22","author":"P Dandache","year":"2008","unstructured":"Dandache, P. & Nadelman, R. B. Erythema migrans. Infectious disease clinics of North America 22, 235\u2013260 (2008).","journal-title":"Infectious disease clinics of North America"},{"key":"29713_CR9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/infdis\/158.4.754","volume":"158","author":"VP Berardi","year":"1988","unstructured":"Berardi, V. P., Weeks, K. E. & Steere, A. C. Serodiagnosis of early Lyme disease: analysis of IgM and IgG antibody responses by using an antibody-capture enzyme immunoassay. J Infect Dis 158, 754\u2013760 (1988).","journal-title":"J Infect Dis"},{"key":"29713_CR10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/jcm.33.2.419-427.1995","volume":"33","author":"SM Engstrom","year":"1995","unstructured":"Engstrom, S. M., Shoop, E. & Johnson, R. C. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 33, 419\u2013427 (1995).","journal-title":"J Clin Microbiol"},{"key":"29713_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF02561539","volume":"27","author":"HA Goossens","year":"1999","unstructured":"Goossens, H. A., Nohlmans, M. K. & van den Bogaard, A. E. Epstein-Barr virus and cytomegalovirus infections cause false-positive results in IgM two-test protocol for early Lyme borreliosis. Infection 27, 231 (1999).","journal-title":"Infection"},{"key":"29713_CR12","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1128\/JCM.01409-14","volume":"52","author":"CR Molins","year":"2014","unstructured":"Molins, C. R. et al. Collection and characterization of samples for establishment of a serum repository for Lyme disease diagnostic test development and evaluation. Journal of clinical microbiology 52, 3755\u20133762 (2014).","journal-title":"Journal of clinical microbiology"},{"key":"29713_CR13","doi-asserted-by":"crossref","unstructured":"Molins, C. R. et al. Development of a metabolic biosignature for detection of early Lyme disease. Clinical Infectious Diseases, civ185 (2015).","DOI":"10.1093\/cid\/civ185"},{"key":"29713_CR14","doi-asserted-by":"publisher","unstructured":"Molins, C. R. et al. Metabolic differentiation of early Lyme disease from southern tick-associated rash illness (STARI). Sci Transl Med 9, https:\/\/doi.org\/10.1126\/scitranslmed.aal2717 (2017).","DOI":"10.1126\/scitranslmed.aal2717"},{"key":"29713_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11306-012-0434-4","volume":"9","author":"WB Dunn","year":"2013","unstructured":"Dunn, W. B. et al. Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics. Metabolomics 9, 44\u201366, https:\/\/doi.org\/10.1007\/s11306-012-0434-4 (2013).","journal-title":"Metabolomics"},{"key":"29713_CR16","first-page":"195","volume":"97","author":"LW Sumner","year":"2007","unstructured":"Sumner, L. W., Huhman, D. V., Urbanczyk-Wochniak, E. & Lei, Z. Methods, applications and concepts of metabolite profiling: secondary metabolism. EXS 97, 195\u2013212 (2007).","journal-title":"EXS"},{"key":"29713_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1189\/jlb.4A0714-339R","volume":"97","author":"AC Love","year":"2015","unstructured":"Love, A. C., Schwartz, I. & Petzke, M. M. Induction of indoleamine 2,3-dioxygenase by Borrelia burgdorferi in human immune cells correlates with pathogenic potential. J Leukoc Biol 97, 379\u2013390, https:\/\/doi.org\/10.1189\/jlb.4A0714-339R (2015).","journal-title":"J Leukoc Biol"},{"key":"29713_CR18","doi-asserted-by":"publisher","unstructured":"Marques, A. et al. Transcriptome Assessment of Erythema Migrans Skin Lesions in Patients with Early Lyme Disease Reveals Predominant Interferon Signaling. J Infect Dis, https:\/\/doi.org\/10.1093\/infdis\/jix563 (2017).","DOI":"10.1093\/infdis\/jix563"},{"key":"29713_CR19","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1128\/JVI.03678-13","volume":"88","author":"WL Liu","year":"2014","unstructured":"Liu, W. L. et al. Epstein-Barr virus infection induces indoleamine 2,3-dioxygenase expression in human monocyte-derived macrophages through p38\/mitogen-activated protein kinase and NF-kappaB pathways: impairment in T cell functions. J Virol 88, 6660\u20136671, https:\/\/doi.org\/10.1128\/JVI.03678-13 (2014).","journal-title":"J Virol"},{"key":"29713_CR20","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1128\/IAI.01202-15","volume":"84","author":"JA Loughman","year":"2016","unstructured":"Loughman, J. A., Yarbrough, M. L., Tiemann, K. M. & Hunstad, D. A. Local Generation of Kynurenines Mediates Inhibition of Neutrophil Chemotaxis by Uropathogenic Escherichia coli. Infect Immun 84, 1176\u20131183, https:\/\/doi.org\/10.1128\/IAI.01202-15 (2016).","journal-title":"Infect Immun"},{"key":"29713_CR21","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1172\/JCI28996","volume":"116","author":"A Popov","year":"2006","unstructured":"Popov, A. et al. Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J Clin Invest 116, 3160\u20133170, https:\/\/doi.org\/10.1172\/JCI28996 (2006).","journal-title":"J Clin Invest"},{"key":"29713_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.imlet.2011.01.009","volume":"136","author":"H Song","year":"2011","unstructured":"Song, H. et al. IDO metabolite produced by EBV-transformed B cells inhibits surface expression of NKG2D in NK cells via the c-Jun N-terminal kinase (JNK) pathway. Immunol Lett 136, 187\u2013193, https:\/\/doi.org\/10.1016\/j.imlet.2011.01.009 (2011).","journal-title":"Immunol Lett"},{"key":"29713_CR23","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/cid\/cir464","volume":"53","author":"JA Branda","year":"2011","unstructured":"Branda, J. A., Linskey, K., Kim, Y. A., Steere, A. C. & Ferraro, M. J. Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay. Clinical infectious diseases 53, 541\u2013547 (2011).","journal-title":"Clinical infectious diseases"},{"key":"29713_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1128\/jcm.27.1.58-61.1989","volume":"27","author":"FW Hyde","year":"1989","unstructured":"Hyde, F. W., Johnson, R. C., White, T. J. & Shelburne, C. E. Detection of antigens in urine of mice and humans infected with Borrelia burgdorferi, etiologic agent of Lyme disease. J Clin Microbiol 27, 58\u201361 (1989).","journal-title":"J Clin Microbiol"},{"key":"29713_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-015-0701-z","volume":"13","author":"R Magni","year":"2015","unstructured":"Magni, R. et al. Application of Nanotrap technology for high sensitivity measurement of urinary outer surface protein A carboxyl-terminus domain in early stage Lyme borreliosis. J Transl Med 13, 346, https:\/\/doi.org\/10.1186\/s12967-015-0701-z (2015).","journal-title":"J Transl Med"},{"key":"29713_CR26","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1128\/CDLI.12.8.910-917.2005","volume":"12","author":"C Rauter","year":"2005","unstructured":"Rauter, C. et al. Critical evaluation of urine-based PCR assay for diagnosis of Lyme borreliosis. Clin Diagn Lab Immunol 12, 910\u2013917, https:\/\/doi.org\/10.1128\/CDLI.12.8.910-917.2005 (2005).","journal-title":"Clin Diagn Lab Immunol"},{"key":"29713_CR27","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1093\/cid\/cir553","volume":"53","author":"HM Feder Jr.","year":"2011","unstructured":"Feder, H. M. Jr. et al. Southern Tick-Associated Rash Illness (STARI) in the North: STARI following a tick bite in Long Island, New York. Clin Infect Dis 53, e142\u2013146, https:\/\/doi.org\/10.1093\/cid\/cir553 (2011).","journal-title":"Clin Infect Dis"},{"key":"29713_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.idc.2015.02.001","volume":"29","author":"RB Nadelman","year":"2015","unstructured":"Nadelman, R. B. Erythema migrans. Infect Dis Clin North Am 29, 211\u2013239, https:\/\/doi.org\/10.1016\/j.idc.2015.02.001 (2015).","journal-title":"Infect Dis Clin North Am"},{"key":"29713_CR29","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1056\/NEJMcp061181","volume":"354","author":"GP Wormser","year":"2006","unstructured":"Wormser, G. P. Clinical practice. Early Lyme disease. N Engl J Med 354, 2794\u20132801, https:\/\/doi.org\/10.1056\/NEJMcp061181 (2006).","journal-title":"N Engl J Med"},{"key":"29713_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix298","author":"AJ Pavletic","year":"2017","unstructured":"Pavletic, A. J. & Marques, A. R. Early Disseminated Lyme Disease Causing False Positive Serology for Primary Epstein-Barr Virus Infection - Report of 2 Cases. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/cix298 (2017).","journal-title":"Clin Infect Dis"},{"key":"29713_CR31","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.jemermed.2017.09.005","volume":"53","author":"R Tumminello","year":"2017","unstructured":"Tumminello, R., Glaspey, L., Bhamidipati, A., Sheehan, P. & Patel, S. Early Disseminated Lyme Disease Masquerading as Mononucleosis: A Case Report. J Emerg Med 53, e133\u2013e135, https:\/\/doi.org\/10.1016\/j.jemermed.2017.09.005 (2017).","journal-title":"J Emerg Med"},{"key":"29713_CR32","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jchromb.2008.11.013","volume":"877","author":"NR Kitteringham","year":"2009","unstructured":"Kitteringham, N. R., Jenkins, R. E., Lane, C. S., Elliott, V. L. & Park, B. K. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci 877, 1229\u20131239, https:\/\/doi.org\/10.1016\/j.jchromb.2008.11.013 (2009).","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"29713_CR33","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1309\/AJCPW0TA8OBBNGCK","volume":"136","author":"FG Strathmann","year":"2011","unstructured":"Strathmann, F. G. & Hoofnagle, A. N. Current and future applications of mass spectrometry to the clinical laboratory. Am J Clin Pathol 136, 609\u2013616, https:\/\/doi.org\/10.1309\/AJCPW0TA8OBBNGCK (2011).","journal-title":"Am J Clin Pathol"},{"key":"29713_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jcf.2010.02.004","volume":"9","author":"BD Wagner","year":"2010","unstructured":"Wagner, B. D., Accurso, F. J. & Laguna, T. A. The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population. Journal of Cystic Fibrosis 9, 212\u2013216 (2010).","journal-title":"Journal of Cystic Fibrosis"},{"key":"29713_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-53","volume":"14","author":"S Mahapatra","year":"2014","unstructured":"Mahapatra, S. et al. A metabolic biosignature of early response to anti-tuberculosis treatment. BMC infectious diseases 14, 1 (2014).","journal-title":"BMC infectious diseases"},{"key":"29713_CR36","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1039\/b921073c","volume":"12","author":"LG Gaines","year":"2010","unstructured":"Gaines, L. G. et al. Effect of creatinine and specific gravity normalization on urinary biomarker 1, 6-hexamethylene diamine. Journal of Environmental Monitoring 12, 591\u2013599 (2010).","journal-title":"Journal of Environmental Monitoring"},{"key":"29713_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ki.2010.165","volume":"78","author":"SS Waikar","year":"2010","unstructured":"Waikar, S. S., Sabbisetti, V. S. & Bonventre, J. V. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney international 78, 486\u2013494 (2010).","journal-title":"Kidney international"},{"key":"29713_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep38243","volume":"6","author":"M Fern\u00e1ndez-Peralbo","year":"2016","unstructured":"Fern\u00e1ndez-Peralbo, M. et al. Prostate Cancer Patients\u2013Negative Biopsy Controls Discrimination by Untargeted Metabolomics Analysis of Urine by LC-QTOF: Upstream Information on Other Omics. Scientific Reports 6, 38243 (2016).","journal-title":"Scientific Reports"},{"key":"29713_CR39","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nprot.2010.50","volume":"5","author":"EJ Want","year":"2010","unstructured":"Want, E. J. et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc 5, 1005\u20131018, https:\/\/doi.org\/10.1038\/nprot.2010.50 (2010).","journal-title":"Nat Protoc"},{"key":"29713_CR40","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1007\/s004670000551","volume":"16","author":"V Chadha","year":"2001","unstructured":"Chadha, V., Garg, U. & Alon, U. S. Measurement of urinary concentration: a critical appraisal of methodologies. Pediatr Nephrol 16, 374\u2013382 (2001).","journal-title":"Pediatr Nephrol"},{"key":"29713_CR41","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jchromb.2009.01.007","volume":"877","author":"BM Warrack","year":"2009","unstructured":"Warrack, B. M. et al. Normalization strategies for metabonomic analysis of urine samples. J Chromatogr B Analyt Technol Biomed Life Sci 877, 547\u2013552, https:\/\/doi.org\/10.1016\/j.jchromb.2009.01.007 (2009).","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"29713_CR42","doi-asserted-by":"crossref","unstructured":"Naviaux, R. K. et al. Metabolic features of chronic fatigue syndrome. Proceedings of the National Academy of Sciences, 201607571 (2016).","DOI":"10.1073\/pnas.1607571113"},{"key":"29713_CR43","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1021\/acs.jproteome.5b00016","volume":"14","author":"MK Das","year":"2015","unstructured":"Das, M. K. et al. Deregulated Tyrosine\u2013Phenylalanine Metabolism in Pulmonary Tuberculosis Patients. Journal of Proteome Research 14, 1947\u20131956, https:\/\/doi.org\/10.1021\/acs.jproteome.5b00016 (2015).","journal-title":"Journal of Proteome Research"},{"key":"29713_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.biopsych.2010.12.006","volume":"70","author":"L Capuron","year":"2011","unstructured":"Capuron, L. et al. Chronic Low-Grade Inflammation in Elderly Persons Is Associated with Altered Tryptophan and Tyrosine Metabolism: Role in Neuropsychiatric Symptoms. Biological Psychiatry 70, 175\u2013182, https:\/\/doi.org\/10.1016\/j.biopsych.2010.12.006 (2011).","journal-title":"Biological Psychiatry"},{"key":"29713_CR45","doi-asserted-by":"crossref","unstructured":"Dias, D. A., Roessner, U. & Jones, O. Applications of metabolomics in the study of pathogenic microorganisms and their effects on human health. Metabolomics and Systems Biology in Human Health and Medicine, 124 (2014).","DOI":"10.1079\/9781780642000.0124"},{"key":"29713_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1146\/annurev.me.26.020175.000301","volume":"26","author":"WR Beisel","year":"1975","unstructured":"Beisel, W. R. Metabolic response to infection. Annual review of medicine 26, 9\u201320 (1975).","journal-title":"Annual review of medicine"},{"key":"29713_CR47","doi-asserted-by":"crossref","unstructured":"Saez-Lara, M. J., Gomez-Llorente, C., Plaza-Diaz, J. & Gil, A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. BioMed research international 2015 (2015).","DOI":"10.1155\/2015\/505878"},{"key":"29713_CR48","doi-asserted-by":"publisher","first-page":"1586S","DOI":"10.1093\/jn\/137.6.1586S","volume":"137","author":"JD Kopple","year":"2007","unstructured":"Kopple, J. D. Phenylalanine and tyrosine metabolism in chronic kidney failure. The Journal of nutrition 137, 1586S\u20131590S (2007).","journal-title":"The Journal of nutrition"},{"key":"29713_CR49","first-page":"461","volume":"58","author":"W Krzy\u015bciak","year":"2011","unstructured":"Krzy\u015bciak, W. Activity of selected aromatic amino acids in biological systems. Acta Biochimica Polonica 58, 461\u2013466 (2011).","journal-title":"Acta Biochimica Polonica"},{"key":"29713_CR50","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.3390\/e15041416","volume":"15","author":"A Samsel","year":"2013","unstructured":"Samsel, A. & Seneff, S. Glyphosate\u2019s suppression of cytochrome P450 enzymes and amino acid biosynthesis by the gut microbiome: pathways to modern diseases. Entropy 15, 1416\u20131463 (2013).","journal-title":"Entropy"},{"key":"29713_CR51","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s11306-015-0816-5","volume":"11","author":"CW Armstrong","year":"2015","unstructured":"Armstrong, C. W., McGregor, N. R., Lewis, D. P., Butt, H. L. & Gooley, P. R. Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients. Metabolomics 11, 1626\u20131639 (2015).","journal-title":"Metabolomics"},{"key":"29713_CR52","doi-asserted-by":"publisher","first-page":"e0153356","DOI":"10.1371\/journal.pone.0153356","volume":"11","author":"KL Liew","year":"2016","unstructured":"Liew, K. L., Jee, J. M., Yap, I. & Yong, P. V. C. In Vitro Analysis of Metabolites Secreted during Infection of Lung Epithelial Cells by Cryptococcus neoformans. Plos one 11, e0153356 (2016).","journal-title":"Plos one"},{"key":"29713_CR53","doi-asserted-by":"crossref","unstructured":"Liang, Q., Liu, H., Wang, C. & Li, B. Phenotypic Characterization Analysis of Human Hepatocarcinoma by Urine Metabolomics Approach. Scientific reports 6 (2016).","DOI":"10.1038\/srep19763"},{"key":"29713_CR54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbi.2012.10.010","volume":"31","author":"JC Felger","year":"2013","unstructured":"Felger, J. C. et al. Tyrosine metabolism during interferon-alpha administration: Association with fatigue and CSF dopamine concentrations. Brain, Behavior, and Immunity 31, 153\u2013160, https:\/\/doi.org\/10.1016\/j.bbi.2012.10.010 (2013).","journal-title":"Brain, Behavior, and Immunity"},{"key":"29713_CR55","doi-asserted-by":"publisher","first-page":"W652","DOI":"10.1093\/nar\/gkp356","volume":"37","author":"J Xia","year":"2009","unstructured":"Xia, J., Psychogios, N., Young, N. & Wishart, D. S. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Research 37, W652\u2013W660, https:\/\/doi.org\/10.1093\/nar\/gkp356 (2009).","journal-title":"Nucleic Acids Research"},{"key":"29713_CR56","doi-asserted-by":"publisher","first-page":"W251","DOI":"10.1093\/nar\/gkv380","volume":"43","author":"J Xia","year":"2015","unstructured":"Xia, J., Sinelnikov, I. V., Han, B. & Wishart, D. S. MetaboAnalyst 3.0\u2014making metabolomics more meaningful. Nucleic Acids Research 43, W251\u2013W257, https:\/\/doi.org\/10.1093\/nar\/gkv380 (2015).","journal-title":"Nucleic Acids Research"},{"key":"29713_CR57","doi-asserted-by":"publisher","first-page":"D603","DOI":"10.1093\/nar\/gkn810","volume":"37","author":"DS Wishart","year":"2009","unstructured":"Wishart, D. S. et al. HMDB: a knowledgebase for the human metabolome. Nucleic acids research 37, D603\u2013D610 (2009).","journal-title":"Nucleic acids research"},{"key":"29713_CR58","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/02664760600708954","volume":"33","author":"M Neuh\u00e4user","year":"2006","unstructured":"Neuh\u00e4user, M. & Hothorn, L. A. A robust modification of the ordered-heterogeneity test. Journal of Applied Statistics 33, 721\u2013727 (2006).","journal-title":"Journal of Applied Statistics"},{"key":"29713_CR59","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria., https:\/\/www.R-project.org\/ (2015)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29713-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29713-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29713-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:33:09Z","timestamp":1671611589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29713-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,15]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29713"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29713-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,15]]},"assertion":[{"value":"6 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Wormser reports receiving research grants from Immunetics, Inc., Institute for Systems Biology, Rarecyte, Inc., and Quidel Corporation. He owns equity in Abbot\/AbbVie; has been an expert witness in malpractice cases involving Lyme disease; and is an unpaid board member of the American Lyme Disease Foundation. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12204"}}